Iovance

Iovance Stock Crashes 35%: Lung Cancer Data Left One Big Question Unanswered

2026-10-29

Iovance Biotherapeutics stock crashed 35.45% on Thursday, October 29, 2026, closing at $9.56, after updated lung cancer data for lifileucel showed a 24.6% response rate in 69 patients — and left ho...